Optimization of region‐of‐interest sampling strategies for hepatic MRI proton density fat fraction quantification
- 26 August 2017
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 47 (4) , 988-994
Abstract
BACKGROUND: Clinical trials utilizing proton density fat fraction (PDFF) as an imaging biomarker for hepatic steatosis have used a laborious region‐of‐interest (ROI) sampling strategy of placing an ROI in each hepatic segment.PURPOSE: To identify a strategy with the fewest ROIs that consistently achieves close agreement with the nine‐ROI strategy.STUDY TYPE: Retrospective secondary analysis of prospectively acquired clinical research data.POPULATION: A total of 391 adults (173 men, 218 women) with known or suspected NAFLD.FIELD STRENGTH/SEQUENCE: Confounder‐corrected chemical‐shift‐encoded 3T MRI using a 2D multiecho gradient‐recalled echo technique.ASSESSMENT: An ROI was placed in each hepatic segment. Mean nine‐ROI PDFF and segmental PDFF standard deviation were computed. Segmental and lobar PDFF were compared. PDFF was estimated using every combinatorial subset of ROIs and compared to the nine‐ROI average.STATISTICAL TESTING: Mean nine‐ROI PDFF and segmental PDFF standard deviation were summarized descriptively. Segmental PDFF was compared using a one‐way analysis of variance, and lobar PDFF was compared using a paired t‐test and a Bland–Altman analysis. The PDFF estimated by every subset of ROIs was informally compared to the nine‐ROI average using median intraclass correlation coefficients (ICCs) and Bland–Altman analyses.RESULTS: The study population's mean whole‐liver PDFF was 10.1 ± 8.9% (range: 1.1–44.1%). Although there was no significant difference in average segmental (P = 0.452) or lobar (P = 0.154) PDFF, left and right lobe PDFF differed by at least 1.5 percentage points in 25.1% (98/391) of patients. Any strategy with ≥4 ROIs had ICC >0.995. 115 of 126 four‐ROI strategies (91%) had limits of agreement (LOA) Level of Evidence: 3Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;47:988–994.Keywords
Funding Information
- NIH (T32 EB005970‐09, R01 DK106419‐02, R01 DK083380, K24 DK102595, R01 DK100651‐03)
This publication has 26 references indexed in Scilit:
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopyJournal of Magnetic Resonance Imaging, 2011
- Addressing phase errors in fat‐water imaging using a mixed magnitude/complex fitting methodMagnetic Resonance in Medicine, 2011
- T1 independent, T2* corrected chemical shift based fat–water separation with multi‐peak fat spectral modeling is an accurate and precise measure of hepatic steatosisJournal of Magnetic Resonance Imaging, 2011
- Estimation of Hepatic Proton-Density Fat Fraction by Using MR Imaging at 3.0 TRadiology, 2011
- Combination of complex‐based and magnitude‐based multiecho water‐fat separation for accurate quantification of fat‐fractionMagnetic Resonance in Medicine, 2011
- Quantification of Liver Fat with Magnetic Resonance ImagingMagnetic Resonance Imaging Clinics of North America, 2010
- Nonalcoholic Fatty Liver Disease: Diagnostic and Fat-Grading Accuracy of Low-Flip-Angle Multiecho Gradient-Recalled-Echo MR Imaging at 1.5 TRadiology, 2009
- Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Relaxation effects in the quantification of fat using gradient echo imagingMagnetic Resonance Imaging, 2008
- Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imagingInternational Journal of Obesity, 2007